Analyst consensus rating
National Healthcare Properties Analyst Rating: Buy
NHP is rated Buy by 7 analysts with a $18.86 target. As of 2026-09-03.
Direct answer
National Healthcare Properties's consensus rating is Buy.
7 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $18.86.
Forecast evidence checked September 3, 2026.
Get free National Healthcare Properties email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $16.14
- Average price target
- $18.86
- High price target
- $24.00
- Low price target
- $16.00
- Low target gap
- -0.9%
- Target upside
- +16.8%
- High target gap
- +48.7%
- Target range width
- 49.6%
- Consensus rating
- Buy
- Analysts
- 7
- Evidence date
- September 3, 2026
- Valid through
- September 10, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for National Healthcare Properties?
National Healthcare Properties has a verified Buy consensus. The same dataset has an average price target of $18.86.
How far are National Healthcare Properties's low and high targets from the recorded price?
The low target implies -0.9%, while the high target implies +48.7%.
How many analysts are included in National Healthcare Properties's consensus?
The verified consensus includes 7 analysts.
How is National Healthcare Properties's target upside or downside calculated?
The average target of $18.86 is divided by the recorded price of $16.14, then one is subtracted to produce +16.8%. This does not guarantee a future return.
When was National Healthcare Properties's analyst forecast verified?
The data was verified on 2026-09-03. The dataset is valid through 2026-09-10.